v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash $ 48,546 $ 17,256
Prepaid expenses, deposits, and other current assets 1,962 1,685
Total current assets 50,508 18,941
Other assets 861 837
Total assets 51,369 19,778
Current liabilities:    
Accounts payable 1,896 2,966
Accrued expenses and other current liabilities 1,133 2,325
CARES Act Paycheck Protection Program note payable 300 300
Senior Secured Convertible Notes - at fair value 10,060
Senior Convertible Note - at fair value 4,600
Total liabilities 3,329 20,251
Commitments and contingencies (Note 4)
Stockholders' Equity (Deficit):    
Common stock, $0.001 par value. Authorized, 150,000,000 shares; issued and outstanding, 81,424,744 shares at March 31, 2021 and 63,819,935 shares at December 31, 2020 81 64
Additional paid-in capital 145,396 87,570
Accumulated deficit (97,778) (88,275)
Total PAVmed Inc. Stockholders' Equity (Deficit) 50,286 1,896
Noncontrolling interests (2,246) (2,369)
Total Stockholders' Equity (Deficit) 48,040 (473)
Total Liabilities and Stockholders' Equity (Deficit) 51,369 19,778
Series B Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficit):    
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,241,438 at March 31, 2021 and 1,228,075 shares at December 31, 2020 $ 2,587 $ 2,537

Source